As part of scientific exchange, Novartis is providing the most recent abstract(s) accepted by the referenced medical congress. The scientific information may include data/information on investigational use(s) of compounds/drugs that efficacy and safety have not been established. Information available on this website is not intended to promote or otherwise commercialize (directly or indirectly) any off-label or unapproved uses of Novartis products.
Not all content may be available. Dependent on congress policy, links to the original poster/slide deck may only be available via the congress site where registration may be needed to access.
Content to be used in accordance with local CPO guidelines
A Multivariate Efficacy Analysis of [177Lu]Lu-DOTA-TATE in the NETTER 2 Study
Marianne Pavel*, Diego Ferone, Daniel Halperin, Sten Myrehaug, Ken Herrmann, Pamela L. Kunz, Beth Chasen, Jaume Capdevila, Salvatore Tafuto, Do-Youn Oh, Changhoon Yoo, Stephen Falk, Thorvardur Halfdanarson, Ilya Folitar, Yufen Zhang, Wouter W. de Herder, Simron Singh
Presentation #1148MO – Mini Oral
Pamplona Auditorium - Hall 3 | Friday, September 13, 2024 | 16:55 - 17:00 CEST (Mini Oral Presentation) | 17:05 - 17:20 (Discussion)
